Montzn-L

Description

Montzn-L is a combination formulation containing Levocetirizine and Montelukast. Levocetirizine is an antihistamine that helps relieve allergy symptoms, while Montelukast is a leukotriene receptor antagonist used in selected allergic and respiratory conditions. A physician may prescribe this combination when both ingredients are considered appropriate for the patient’s symptoms and medical history.

Montzn-L is supplied in a 60 ml bottle with a carton and is listed under the Paediatric and General Practitioner (G.P.) therapeutic segments.

Therapeutic Segment

Anti-Allergic Range | Allergy Care | Paediatric + G.P.

Uses of Montzn-L

Montzn-L may be prescribed by a healthcare professional for selected allergic conditions, depending on the patient’s diagnosis. These may include:

• Relief of allergy symptoms such as sneezing, a runny nose and nasal itching.
• Management of selected allergic conditions when an antihistamine and a leukotriene receptor antagonist are both considered appropriate.
• Allergy-related symptoms associated with certain respiratory conditions, when specifically advised by a physician.

Montelukast is not intended to provide immediate relief from an acute asthma attack. This combination should not be used for self-treatment without medical advice.

Key Features of Montzn-L

• Contains Levocetirizine and Montelukast.
• Combines an antihistamine with a leukotriene receptor antagonist.
• Supplied in a 60 ml bottle with carton.
• Listed for Paediatric and G.P. segments.
• Intended for use under professional medical guidance.

How Does Montzn-L Work?

Levocetirizine blocks histamine H1 receptors, helping reduce allergy symptoms such as sneezing, nasal itching and a runny nose.

Montelukast blocks leukotrienes, inflammatory substances that can contribute to allergic symptoms and airway inflammation. The two ingredients work through different mechanisms, but the combination is appropriate only when a healthcare professional determines that both are needed.

Possible Side Effects

Possible side effects may include:

• Sleepiness or drowsiness
• Headache
• Dry mouth
• Stomach discomfort
• Fatigue

Montelukast has also been associated with serious mood and behaviour-related changes, including sleep disturbances, agitation, depression and suicidal thoughts or behaviour. Seek medical advice promptly if new or unusual behavioural or mood changes occur.

Important Safety Information

• Use Montzn-L only as directed by a qualified physician.
• Confirm the appropriate product strength and dose for the child’s age and condition before use.
• Levocetirizine may cause drowsiness. Avoid activities requiring alertness if affected.
• Inform the physician about kidney problems, other medical conditions and all medicines being taken.
• Watch for new changes in mood, sleep, behaviour or thoughts while taking Montelukast. Contact a healthcare professional promptly if these occur.
• Montzn-L is not a rescue medicine for sudden breathing difficulty or an acute asthma attack.
• Do not exceed the prescribed dose or combine it with other allergy medicines unless advised by a physician.

Dosage and Administration

The appropriate dose and frequency depend on the patient’s age, diagnosis, the approved concentration and the physician’s instructions. Use a suitable measuring device and follow the product label.

Composition clarification: The supplied details list Levocetirizine 2.5 mg and Montelukast 4 mg but do not specify the volume to which these strengths apply. Confirm whether the strengths are per 5 ml or another volume before publishing or providing dosage instructions.

Storage

Store according to the approved product label. Keep the bottle tightly closed, out of reach of children, and do not use after the expiry date.